华邦健康
(002004)
| 流通市值：79.05亿 | | | 总市值：83.16亿 |
| 流通股本：18.82亿 | | | 总股本：19.80亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,887,675,227.71 | 3,289,723,455.66 | 3,639,754,636.68 | 3,869,597,463.56 |
| 应收票据及应收账款 | 2,354,210,509.05 | 2,245,133,555.84 | 2,574,723,692.63 | 2,368,083,378.54 |
| 其中：应收票据 | 112,291,621.26 | 75,173,492.02 | 208,760,750.61 | 196,802,156.6 |
| 应收账款 | 2,241,918,887.79 | 2,169,960,063.82 | 2,365,962,942.02 | 2,171,281,221.94 |
| 应收款项融资 | 326,689,997.32 | 294,685,115.45 | 274,899,906.38 | 263,774,691.79 |
| 预付款项 | 124,344,179.84 | 101,065,536.74 | 175,703,413.53 | 139,465,990.4 |
| 其他应收款合计 | 581,293,219.95 | 579,003,823.62 | 701,917,565.15 | 775,905,968.66 |
| 其中:应收利息 | 12,158,898.47 | 12,803,741.96 | 6,800,187.74 | 8,017,919.83 |
| 应收股利 | 0 | 0 | - | 18,950,000 |
| 存货 | 2,278,665,903.34 | 2,253,400,907.02 | 2,363,782,001.1 | 2,490,337,051 |
| 合同资产 | 15,542,037.52 | 14,617,204.76 | 11,582,640.75 | 10,013,007.19 |
| 一年内到期的非流动资产 | 21,517,095.89 | 21,517,095.89 | 1,293,569.86 | 1,314,803.19 |
| 其他流动资产 | 1,649,651,723.48 | 1,823,686,793.4 | 1,449,194,973.92 | 1,326,564,124.71 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 11,760,657,341.32 | 11,276,705,434.24 | 11,788,700,071.67 | 11,774,867,639.42 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,352,879,620.96 | 2,338,769,526.85 | 2,556,028,978.4 | 2,640,624,861.39 |
| 其他权益工具投资 | 124,913,284.71 | 124,913,284.54 | 127,022,523.73 | 127,164,031.38 |
| 其他非流动金融资产 | 358,897.09 | 358,897.09 | 434,924.67 | 434,924.67 |
| 投资性房地产 | 839,412,619.57 | 847,672,192.52 | 856,011,285.43 | 862,989,961.91 |
| 固定资产 | 8,082,138,834.27 | 8,332,173,058.24 | 7,586,021,516.49 | 7,494,672,960.21 |
| 在建工程 | 1,273,629,255.62 | 1,153,520,680.27 | 2,065,290,590.32 | 2,140,930,928.51 |
| 生产性生物资产 | 25,898,331.48 | 26,167,013.79 | 26,451,292.95 | 26,649,903.62 |
| 使用权资产 | 406,343,649.37 | 414,034,880.17 | 410,293,442.88 | 416,674,893.01 |
| 无形资产 | 1,535,079,147.4 | 1,525,907,524.07 | 1,543,564,971.16 | 1,561,633,058.49 |
| 开发支出 | 63,234,689.01 | 92,949,701.83 | 80,016,653.11 | 72,905,642.05 |
| 商誉 | 2,032,372,107.36 | 2,032,372,107.36 | 2,739,933,395.2 | 2,739,933,395.2 |
| 长期待摊费用 | 464,149,063 | 482,120,219.83 | 498,745,693.02 | 503,648,321.78 |
| 递延所得税资产 | 583,872,043.6 | 525,929,164.94 | 513,874,829.54 | 498,389,328.01 |
| 其他非流动资产 | 293,646,731.44 | 276,875,648.87 | 270,264,688.04 | 271,455,101.2 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 18,077,928,274.88 | 18,173,763,900.37 | 19,273,954,784.94 | 19,358,107,311.43 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 29,838,585,616.2 | 29,450,469,334.61 | 31,062,654,856.61 | 31,132,974,950.85 |
| 流动负债: | | | | |
| 短期借款 | 4,018,523,258.31 | 3,560,952,631.78 | 4,018,256,650.3 | 4,846,563,618.95 |
| 交易性金融负债 | - | - | 586,961.84 | 610,946.58 |
| 应付票据及应付账款 | 2,164,295,741.91 | 2,265,617,404.64 | 2,312,245,531.28 | 2,256,524,042.83 |
| 其中：应付票据 | 931,073,321.79 | 867,249,478.21 | 834,701,431.98 | 715,943,116.06 |
| 应付账款 | 1,233,222,420.12 | 1,398,367,926.43 | 1,477,544,099.3 | 1,540,580,926.77 |
| 预收款项 | 18,013,159.02 | 20,864,955.19 | 11,951,561.82 | 9,325,800.49 |
| 合同负债 | 113,285,447.03 | 225,513,904.85 | 169,521,623.9 | 110,812,597.77 |
| 应付职工薪酬 | 174,433,061.55 | 343,318,060.13 | 182,845,037.16 | 154,240,951.86 |
| 应交税费 | 167,525,897.89 | 226,158,077.01 | 268,836,426.29 | 228,466,266.1 |
| 其他应付款合计 | 1,467,877,374.72 | 1,421,539,115.41 | 1,706,212,614.55 | 1,752,484,568.23 |
| 应付股利 | 9,501,204.82 | 14,445,924.82 | 2,008,330.82 | 71,850,939.02 |
| 一年内到期的非流动负债 | 2,228,603,901.31 | 2,331,881,781.7 | 1,901,537,449.92 | 1,878,177,652.29 |
| 其他流动负债 | 8,706,728.7 | 19,214,895.55 | 16,364,296.53 | 11,691,298.76 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 10,361,264,570.44 | 10,415,060,826.26 | 10,588,358,153.59 | 11,248,897,743.86 |
| 非流动负债: | | | | |
| 长期借款 | 2,584,421,449.06 | 2,398,848,937.41 | 2,913,200,189.33 | 2,619,464,820.98 |
| 应付债券 | 551,628,185.9 | 544,399,479.13 | 505,672,675.16 | 376,947,887.07 |
| 租赁负债 | 55,679,865.05 | 53,417,964.78 | 50,407,596.3 | 50,271,969.7 |
| 长期应付款 | 193,861,351.07 | 193,841,391.07 | 193,864,881.07 | 193,944,917.07 |
| 递延收益 | 263,959,415.43 | 266,869,601.15 | 250,645,314.49 | 261,772,939.9 |
| 递延所得税负债 | 104,141,181.65 | 104,621,815.44 | 105,972,419.84 | 109,272,421.63 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 3,753,691,448.16 | 3,561,999,188.98 | 4,019,763,076.19 | 3,611,674,956.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 14,114,956,018.6 | 13,977,060,015.24 | 14,608,121,229.78 | 14,860,572,700.21 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,979,919,191 | 1,979,919,191 | 1,979,919,191 | 1,979,919,191 |
| 资本公积 | 5,306,142,064.44 | 5,304,404,857.84 | 5,336,511,950.47 | 5,313,547,712.3 |
| 减:库存股 | 29,999,210.13 | 29,999,210.13 | 29,499,256.13 | 24,966,124.13 |
| 其他综合收益 | -112,926,280.83 | -118,572,991.23 | -134,346,359.35 | -116,572,990.56 |
| 专项储备 | 18,391,735.67 | 17,907,943.53 | 19,642,152.96 | 17,020,808.01 |
| 盈余公积 | 585,396,351.44 | 585,396,351.44 | 583,150,555.63 | 583,150,555.63 |
| 未分配利润 | 1,782,342,372.04 | 1,598,002,031.15 | 2,353,494,940.4 | 2,215,085,422.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,529,266,223.63 | 9,337,058,173.6 | 10,108,873,174.98 | 9,967,184,574.77 |
| 少数股东权益 | 6,194,363,373.97 | 6,136,351,145.77 | 6,345,660,451.85 | 6,305,217,675.87 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 15,723,629,597.6 | 15,473,409,319.37 | 16,454,533,626.83 | 16,272,402,250.64 |
| 负债和股东权益合计 | 29,838,585,616.2 | 29,450,469,334.61 | 31,062,654,856.61 | 31,132,974,950.85 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-29 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |